These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 311940)

  • 21. [Long-term therapy of progressive chronic polyarthritis with naproxen].
    Boost G
    Arzneimittelforschung; 1975 Feb; 25(2A):298-302. PubMed ID: 807223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [How long should antithrombotic therapy be continued following aortocoronary bypass surgery?].
    Pfisterer M; Jockers G; Regenass S; Schmitt HE; Grädel E; Burkart F
    Schweiz Med Wochenschr; 1989 Oct; 119(43):1518-20. PubMed ID: 2692145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of naproxen on the steady-state serum concentration and anticoagulant activity of warfarin.
    Jain A; McMahon FG; Slattery JT; Levy G
    Clin Pharmacol Ther; 1979 Jan; 25(1):61-6. PubMed ID: 758244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Improved flow through aortocoronary venous bypasses after anticoagulant therapy. A prospective randomized study].
    Gohlke H; Gohlke-Bärwolf C; Stürzenhofecker P; Görnandt L; Ritter B; Reichelt M; Buchwalsky R; Schmuziger M; Roskamm H
    Schweiz Med Wochenschr; 1981 Nov; 111(45):1722-4. PubMed ID: 6975997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Blood coagulation monitoring in oral anticoagulant therapy using chromogenic substances].
    Pindur G; Seifried E; Joos A; Rasche H
    Med Lab (Stuttg); 1981; 34(3):88-91. PubMed ID: 7231353
    [No Abstract]   [Full Text] [Related]  

  • 26. [The blood coagulation status and the immunochemical and clinical indices in patients with active rheumatism during treatment with nerobol].
    Likhatskaia VA; Epishin AV; Furtel' PA
    Lab Delo; 1991; (8):42-4. PubMed ID: 1724507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lead concentration in blood during treatment with coumarin derivatives].
    Fischer H; Wehran HI
    Z Arztl Fortbild (Jena); 1978 Mar; 72(5):211. PubMed ID: 418581
    [No Abstract]   [Full Text] [Related]  

  • 28. [Observations of long-term treatment of arthrosis with naproxen].
    Rau R
    Arzneimittelforschung; 1975 Feb; 25(2A):325-7. PubMed ID: 1096905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antipyretic effect of naproxen in neoplastic fever].
    Kondo M; Ando Y; Tominaga S; Nakayama T; Kuribayashi T; Hashimoto S
    Gan No Rinsho; 1987 Sep; 33(11):1347-52. PubMed ID: 3669320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenprocoumon requirement, whole blood coagulation time, bleeding time and plasma gamma-GT in patients receiving mianserin.
    Kopera H; Schenk H; Stulemeijer S
    Eur J Clin Pharmacol; 1978 Jul; 13(5):351-6. PubMed ID: 27373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heart transplantation under coumarin therapy: friend or foe?
    Karck M; Haverich A
    Eur J Anaesthesiol; 1994 Nov; 11(6):475-9. PubMed ID: 7851355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased serum osteocalcin levels in phenprocoumon-treated patients.
    Pietschmann P; Woloszczuk W; Panzer S; Kyrle P; Smolen J
    J Clin Endocrinol Metab; 1988 May; 66(5):1071-4. PubMed ID: 3258869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction between phenprocoumon and phytomenadion: a pharmacokinetic investigation in healthy volunteers.
    Haustein KO
    Biomed Biochim Acta; 1984; 43(12):1417-24. PubMed ID: 6534380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical experience with naproxen in rheumatoid arthritis.
    Alexander SJ
    Arch Intern Med; 1975 Nov; 135(11):1429-35. PubMed ID: 1103765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of influenza vaccine in patients receiving long-term warfarin therapy.
    Weibert RT; Lorentz SM; Norcross WA; Klauber MR; Jagger PI
    Clin Pharm; 1986 Jun; 5(6):499-503. PubMed ID: 3720216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prevention of sequelae after myocardial infarct. Results, methods and problems of a prospective multi-center study of the effect of acetylsalicylic acid, phenprocoumon and placebo].
    Breddin HK; Uberla KK
    Verh Dtsch Ges Inn Med; 1980; 86():1338-48. PubMed ID: 7013326
    [No Abstract]   [Full Text] [Related]  

  • 37. [Analysis of phenprocoumon dose regulation based on measurement of coagulation factors II, VII and X].
    Heaf JG
    Ugeskr Laeger; 1992 Apr; 154(15):1036-9. PubMed ID: 1566514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenylbutazone and sulfinpyrazone interaction with oral anticoagulant phenprocoumon.
    O'Reilly RA
    Arch Intern Med; 1982 Sep; 142(9):1634-7. PubMed ID: 7114982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of arterial and pulmonary embolism by oral anticoagulants in patients with dilated cardiomyopathy.
    Kyrle PA; Korninger C; Gössinger H; Glogar D; Lechner K; Niessner H; Pabinger I
    Thromb Haemost; 1985 Aug; 54(2):521-3. PubMed ID: 4082088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of alclofenac on the prothrombin level in patients under treatment with anticoagulants].
    Kaufmann E
    Schweiz Med Wochenschr; 1977 Jun; 107(25):882-7. PubMed ID: 18796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.